Menarini Hellas
The International Pharmacy Group Menarini, started its activity in Greece in 1989, buying the 70% of Damvergis SA, a traditional pharmaceutical industry with presence in Greece since 1935.
In 1996 the Menarini Group acquired the 100% of the share capital of Damvergιs SA, renaming its subsidiary in Greece to Menarini Hellas A.E.
Since 1989, the company has launched many innovative and prototype pharmaceutical treatments in the Pharmaceutical Market, mainly in the cardiovascular and respiratory system, but also in other major therapeutic categories.
The successful course of the company for the past 30 years has established Menarini Hellas as a new and dynamic company in the Pharmaceutical Market which is already among the largest Pharmaceutical companies in Greece and employs 280 employees.
Number of Employees (31/12/2009):
178
Turnover (31/12/2009):
46.380.909,33€
Representation:
A. Menarini I.F.R. Srl (Italy), Menarini International Operations Luxembourg SA (Luxembourg ), Meda Manufacturing GMBH
MISSION
To make an active contribution so as to improve the human health through the launch of high-quality prototype pharmaceuticals.
VISION
To make Menarini Hellas a reliable and highly effective company in promoting high quality pharmaceutical products while demonstrating high social responsibility and sensitivity as well as becoming the ideal partner of major international pharmaceutical companies and research firms.
PHARMACEUTICAL COMPOUNDS PER DISEASE
CONTACT
General Manager: Grigoris Politis
Address: 16-18, Patmou, 15123 – Marousi-Athens, Greece
- Telephone:+30 (210) 8316111-13
- Fax:+30 (210) 8317343
- Website: www.menarini.gr
- Email: [email protected]